Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Turkheimer

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Molecular Psychiatry|June 6, 2012
Measuring endogenous changes in serotonergic neurotransmission in humans: a [11C]CUMI-101 PET challenge studyS Selvaraj, F Turkheimer, L Rosso, et al.
Neuroscience and Biobehavioral Reviews|December 11, 2017
Obstructive sleep apnoea and Alzheimer's disease: In search of shared pathomechanismsD Polsek, N Gildeh, D Cash, et al.
Brain, Behavior, and Immunity|March 8, 2022
Transcriptomic and cellular decoding of functional brain connectivity changes reveal regional brain vulnerability to pro- and anti-inflammatory therapiesD Martins, O Dipasquale, K Davies, et al.
European Archives of Psychiatry and Clinical Neuroscience|December 31, 2013
Neuropathological changes in the substantia nigra in schizophrenia but not depressionM R Williams, K Galvin, B O'Sullivan, et al.
Experimental Neurology|December 24, 2024
Early alterations of functional connectivity, regional brain volumes and astrocyte markers in the beta-sitosterol beta-d-glucoside (BSSG) rat model of parkinsonismC Monnot, M Kalomoiri, E MacNicol, et al.
Neurology|September 10, 2003
[11C](R)-PK11195 PET imaging of microglial activation in multiple system atrophyA Gerhard, R B Banati, G B Goerres, et al.
Brain : a Journal of Neurology|October 26, 2000
The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activityR B Banati, J Newcombe, R N Gunn, et al.
Translational Psychiatry|August 30, 2017
PET imaging of putative microglial activation in individuals at ultra-high risk for psychosis, recently diagnosed and chronically ill with schizophreniaM A Di Biase, A Zalesky, G O'keefe, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Molecular Psychiatry|June 6, 2012
Measuring endogenous changes in serotonergic neurotransmission in humans: a [11C]CUMI-101 PET challenge studyS Selvaraj, F Turkheimer, L Rosso, et al.
Neuroscience and Biobehavioral Reviews|December 11, 2017
Obstructive sleep apnoea and Alzheimer's disease: In search of shared pathomechanismsD Polsek, N Gildeh, D Cash, et al.
Brain, Behavior, and Immunity|March 8, 2022
Transcriptomic and cellular decoding of functional brain connectivity changes reveal regional brain vulnerability to pro- and anti-inflammatory therapiesD Martins, O Dipasquale, K Davies, et al.
European Archives of Psychiatry and Clinical Neuroscience|December 31, 2013
Neuropathological changes in the substantia nigra in schizophrenia but not depressionM R Williams, K Galvin, B O'Sullivan, et al.
Experimental Neurology|December 24, 2024
Early alterations of functional connectivity, regional brain volumes and astrocyte markers in the beta-sitosterol beta-d-glucoside (BSSG) rat model of parkinsonismC Monnot, M Kalomoiri, E MacNicol, et al.
Neurology|September 10, 2003
[11C](R)-PK11195 PET imaging of microglial activation in multiple system atrophyA Gerhard, R B Banati, G B Goerres, et al.
Brain : a Journal of Neurology|October 26, 2000
The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activityR B Banati, J Newcombe, R N Gunn, et al.
Translational Psychiatry|August 30, 2017
PET imaging of putative microglial activation in individuals at ultra-high risk for psychosis, recently diagnosed and chronically ill with schizophreniaM A Di Biase, A Zalesky, G O'keefe, et al.
Pageof 2